How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?
View as a Web Page
News Medical
 
  Pulmonology Pulmonology logo  
  The latest pulmonology news from News Medical  
 Can one AI analyze all medical scans? MedVersa shows promise across multiple imaging tasksCan one AI analyze all medical scans? MedVersa shows promise across multiple imaging tasks
 
esearchers developed MedVersa, a generalist multimodal AI model trained on tens of millions of medical imaging instances to perform diverse radiology tasks within a single framework. The model matched or exceeded specialist AI systems across several benchmarks and produced radiology reports comparable to human reports in many cases while improving reporting efficiency.
 
 
 How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?
 
A comprehensive Lancet review synthesizes evidence from major clinical trials showing that GLP-1 receptor agonists and next-generation incretin therapies deliver substantial weight loss while reducing cardiovascular and kidney risks. Emerging dual, triple, and oral agents may further expand treatment options and improve outcomes across obesity, type 2 diabetes, and related metabolic diseases.
 
   Nonadherence to COPD medication increases hospital admissions and mortalityNonadherence to COPD medication increases hospital admissions and mortality
 
Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads to increased exacerbations and faster lung function decline, according to two new studies.
 
   DNA nanomachine strategy reverses chemoresistance in small cell lung cancerDNA nanomachine strategy reverses chemoresistance in small cell lung cancer
 
Professor Chao Zhang's team at Zhujiang Hospital, Southern Medical University, has developed a novel DNA nanomachine-based drug delivery and release strategy aimed at overcoming chemoresistance in small cell lung cancer (SCLC).
 
   Distinct spatial tumor–immune ecosystems predict lung cancer treatment responseDistinct spatial tumor–immune ecosystems predict lung cancer treatment response
 
Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.
 
 Gut microbiota-derived metabolite directly shapes immune responses in bacterial pneumonia
 
Gut microbiota-derived metabolite directly shapes immune responses in bacterial pneumoniaSepsis and severe pneumonia are frequently accompanied by disruption of the gut microbiota, leading to immune dysfunction and increased susceptibility to secondary infections.
 
 
 New cell-free method reveals hidden rules of bacterial gene expression
 
New cell-free method reveals hidden rules of bacterial gene expressionInside every cell, thousands of molecular signals collide, overlap, and compensate, obscuring the true drivers of gene expression.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026